PAVmed Inc. (NASDAQ:PAVMZ) Short Interest Update

PAVmed Inc. (NASDAQ:PAVMZ) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totalling 5,200 shares, a decline of 66.0% from the March 31st total of 15,300 shares. Based on an average daily volume of 9,200 shares, the short-interest ratio is presently 0.6 days.

PAVmed Price Performance

PAVMZ traded down $0.01 during midday trading on Thursday, reaching $0.02. The company’s stock had a trading volume of 35,055 shares, compared to its average volume of 11,478. The stock’s 50-day moving average is $0.04 and its 200-day moving average is $0.08. PAVmed has a 1 year low of $0.00 and a 1 year high of $0.27.

About PAVmed

PAVmed Inc focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck.